Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer

Nowadays we have novel therapies for advanced stage non-small cell lung cancer. Immunotherapy has been introduced in the market for several years and until now its administration is mostly based on the programmed death-ligand 1. First line treatment with immunotherapy can be administered alone if pr...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Chrysanthi Sardeli, Paul Zarogoulidis, Konstantinos Romanidis, Panagoula Oikonomou, Konstantinos Sapalidis, Haidong Huang, Chong Bai, Wolfgang Hohenforst-Schmidt, Kosmas Tsakiridis, Bojan Zaric, Branislav Perin, Aris Ioannidis, Sofia Baka, Konstantinos Drevelegas, Maria Kosmidou, Christoforos Kosmidis
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2020-01-01
Цуврал:	Respiratory Medicine Case Reports
Нөхцлүүд:	Immunotherapy Non-small cell lung cancer Pneumothorax Pembrolizumab EBUS
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S221300712030472X
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!